0000899243-22-026139.txt : 20220715 0000899243-22-026139.hdr.sgml : 20220715 20220715180030 ACCESSION NUMBER: 0000899243-22-026139 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220713 FILED AS OF DATE: 20220715 DATE AS OF CHANGE: 20220715 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Berland Susan D CENTRAL INDEX KEY: 0001307002 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40440 FILM NUMBER: 221087774 MAIL ADDRESS: STREET 1: C/O SENTI BIOSCIENCES, INC. STREET 2: 2 CORPORATE DRIVE, FIRST FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Senti Biosciences, Inc. CENTRAL INDEX KEY: 0001854270 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 862437900 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 CORPORATE DRIVE, FIRST FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 382-3281 MAIL ADDRESS: STREET 1: 2 CORPORATE DRIVE, FIRST FLOOR CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: Senti Biosciences, Inc.\ DATE OF NAME CHANGE: 20220615 FORMER COMPANY: FORMER CONFORMED NAME: Dynamics Special Purpose Corp. DATE OF NAME CHANGE: 20210331 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-07-13 0 0001854270 Senti Biosciences, Inc. SNTI 0001307002 Berland Susan D C/O SENTI BIOSCIENCES, INC. 2 CORPORATE DRIVE FIRST FLOOR SOUTH SAN FRANCISCO CA 94080 1 0 0 0 Stock Option (Right to Buy) 1.75 2022-07-13 4 A 0 125000 0.00 A 2032-07-12 Common Stock 125000 125000 D The shares underlying this option vest in 36 substantially equal monthly installments over three years from July 13, 2022, subject to the reporting person's continued service through the applicable vesting date. The vested shares subject to such option shall be exercisable upon the effectiveness of the Issuer's registration statement on Form S-8, registering the shares of the Issuer's 2022 Equity Incentive Plan with the U.S. Securities and Exchange Commission. /s/ Mike Rhee, attorney-in-fact 2022-07-15